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A 33-year-old male patient presented with 
gradual and progressive protrusion of his 
left eye. He had a history of rhinoplasty for 
correction of nasal septal deviation 10 years 
ago. The patient developed intermittent bloody 
nasal discharge one year after rhinoplasty 
and underwent diagnostic paranasal sinus 
endoscopy and maxillary sinus antrostomy and 
biopsy. Histopathological studies had revealed 
a granulomatous leukocytoclastic vasculitis 
compatible with Wegener’s granulomatosis 
(WG). Treatment with prednisolone 25 mg/
day and Endoxan (cyclophosphamide) 100 mg/
day was initiated until orbital symptoms and 
signs appeared, 6 years later. At the time of 
presentation, uncorrected visual acuity was 
20/20 in both eyes without relative afferent 
pupillary defect. Exophthalmometric readings 
were 22 and 27 mm on the right and left side, 
respectively.
In addition, saddle nose deformity was 
noted (Fig. 1). Mild limitation of ocular 
movements was present in his left eye. Slit lamp 
biomicroscopy, tonometry and funduscopy were 
unremarkable in both eyes. Orbital computed 
tomography (CT) and magnetic resonance 
imaging (MRI) scans (Figures 2 and 3) revealed 
Figure 1. Anterior and lateral appearance of the patient. 
Note the bilateral proptosis, more marked on the left 
side, eyelid edema and saddle nose deformity.
Figure 2. Axial (top) and coronal (bottom) sections on 
orbital computed tomography. Homogenous extraconal 
orbital mass lesions are seen on both sides adjacent to 
the medial walls. Bone erosion and destruction of the 
medial wall and nasal septum are also noted. The globes 
are displaced anteriorly and laterally especially on the 
left side.Photo Essay; Aletaha et al
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destruction of the nasal septum and bilateral 
orbital mass lesions. 
All laboratory tests including antineutrophil 
cytoplasmic antibody (cANCA, pANCA), 
rheumatoid factor, lupus erythematosus cell, 
C-reactive protein and HLA typing (HLA-B12 
and HLA-B5) were negative.
Excisional biopsy of the left orbital mass 
through a Lynch incision was performed 
and the mass was completely removed 
(Fig. 4). Histopathological examination of the 
specimen confirmed granulomatous vasculitis 
compatible with WG (Fig. 5). Anti-inflammatory 
medications were continued. The rheumatologist 
recommended excisional biopsy of the right 
orbital mass as well, but the patient declined 
further intervention. 
DISCuSSION 
WG is a systemic disorder that mainly involves the 
upper and lower respiratory tracts and kidneys. 
It is characterized by granuloma formation, 
necrosis and small vessel inflammation on 
histopathological examination. Some forms of 
the disease are limited to the respiratory tract 
without renal involvement. WG is presumed to 
be autoimmune but its exact nature is unknown; 
it is believed that infectious agents may trigger 
the disease. Sinus involvement leads to mucosal 
thickening, ulceration and recurrent bleeding. 
Chronic and recurrent inflammation may cause 
scarification and destruction of the sinuses 
Figure 3. Orbital magnetic resonance imaging shows 
heterogenous bilateral orbital mass lesions adjacent to 
the medial walls. The lesions have moderate intensity, 
similar to muscle on axial T1-weighted (top) and low 
intensity on axial T2-weighted images (middle). On 
coronal fat suppression T1-weighted view with contrast 
(bottom) the lesions show marked heterogenous 
enhancement. Diffuse mucosal thickening in the 
paranasal sinuses and absence of the nasal septum are 
seen in all images.
Figure 4. Gross anatomy of the excised mass. Firm 
consistency and yellowish color of the lesion are similar 
to that of cartilage.Photo Essay; Aletaha et al
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leading to impaired drainage and normal 
function. Surgical intervention may be required 
for treatment of recurrent infections.1,2
Ocular manifestations such as orbital 
inflammatory disease, scleritis, episcleritis, and 
peripheral ulcerative keratitis are major causes 
of morbidity which occur in more than 50% of 
patients with WG. Orbital involvement usually 
presents with proptosis, occasional pain, eyelid 
edema and limitation of ocular movements and 
is the most prevalent ocular involvement by 
WG.3 In a large 16-year survey, 140 patients 
with biopsy-proven WG were examined and 
orbital disease was reported as the most common 
ocular involvement in 15% of cases.4 Similar 
results have been reported by other authors.1,5 
Orbital involvement usually present several 
years after the onset of the disease (as in our 
patient), however the ophthalmologist may be 
the first physician who faces a patient with 
WG. Therefore this condition should always be 
considered in patients with orbital mass lesions 
and chronic sinus disease.1,6 Orbital inflammatory 
disease in WG may develop as a result of primary 
granulomatous vasculitis or more commonly 
following extension of sinus involvement into 
the orbital cavity. In the latter condition, orbital 
involvement is usually extraconal but may later 
extend into the muscle cone.7 
Despite the high prevalence of orbital 
granulomatous disease in WG, bilateral 
involvement is uncommon. Bilateral orbital 
lesions due to concomitant sinus disease were 
reported in 2 out of 11 patients by Bullen et al4. 
Differential diagnosis for bilateral orbital mass 
lesions includes systemic metastasis, lymphoma, 
leukemia and other types of orbital vasculitis.8 
Definitive diagnosis of WG is based on 
tissue biopsy. Histopathological findings include 
the classic triad of vasculitis, granulomatous 
inflammation (with or without giant cells) and 
tissue necrosis; however, the full picture may 
not be seen in one specimen.9
In summary, WG should be considered in 
patients with uni- or bilateral localized orbital 
mass lesions especially those with underlying 
chronic paranasal sinus disease, with or without 
systemic involvement. Prompt treatment with 
potent immunosuppressive agents including 
cyclophosphamide is necessary to improve 
visual and systemic prognosis.
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